Goldman Sachs upgraded its rating on shares of Quest Diagnostics Inc. (DGX) Thursday morning to "Buy" from "Neutral."
Quest Diagnostics gapped open higher Thursday and has continued to rise in early trade. Shares are now up 2.03 at $59.33. The stock has climbed to a 2 1/2 month high and has re-crossed its 200-day moving average.
For comments and feedback: editorial@rttnews.com